Table 1.

 Patient characteristics

	N = 94	%
Gender
Male	60	63.8
Female	34	36.2
Age
Median	59 (12–82)
≥60	45	47.9
<60	49	52.1
LDH (n = 84)†
Normal	53	63.1
≥Normal	31	36.9
Hemoglobin (n = 83)†
≥12 g/dL	48	57.8
<12 g/dL	35	42.2
ALC (n = 83)†
≥1.0 × 109/L	62	74.7
<1.0 × 109/L	21	25.3
PS (ECOG)
0–1	86	91.5
2	8	8.5
B symptom
A	77	81.9
B	17	18.1
IPI (n = 87)†
Low	9	10.6
Low‐intermediate	38	43.7
High‐intermediate	30	34.5
High	10	11.5
MZLPI
Intermediate	59	62.8
High	35	37.2

†Number of available patient’s data. ALC, absolute lymphocyte count; IPI, International Prognostic Index; LDH, lactic dehydrogenase; MZLPI, Marginal Zone B‐cell Lymphoma Prognostic Index; PS (ECOG), performance status (Eastern Cooperative Oncology Group).